Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Up to 97% of NAION patients have small optic discs with small or absent cups, representing the strongest risk factor
And by 2024, the figure reached $300 million
*Correspondence: Jinhua Li, [email protected] Zhang, [email protected] These authors have contributed equally to this work ORCID: Jinhua Li, orcid.org/0000-0003-0085-9168 Xu Wang, orcid.org/0009-0007-7157-7156 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Gerstberger, S., Jiang, Q
Protocol for a randomized phase II/III double-blind placebo-controlled trial to evaluate the safety and efficacy of extended-release metformin in amnestic mild cognitive impairment: metformin in Alzheimer dementia prevention (MAP)
US$ 22.68
US$ 27.84
US$ 24.96
US$ 21.24
US$ 21.84
US$ 27.32
US$ 21.66
US$ 23.02
